美股A股
StockGist
Back
10-Q2026-05-11· grok-4-1-fast-non-reasoning

OPXS · Optex Systems Holdings, Inc

0001493152-26-022219

SEC filing

Summary

Mixed Q2 results showed revenue declining 10.3% to $9.6M from government contract timing pressures, offset by gross profit stability at $3.4M and 35.2% margin resilience, though operating income fell 25.6% to $1.7M amid elevated G&A investments.

Key takeaways

Full analysis

Optex Systems Holdings, Inc. (OPXS) reported Q2 FY2026 results reflecting revenue timing challenges offset by gross margin strength and strategic investments. Revenue of $9.6M declined 10.3% from $10.7M in the prior-year quarter, primarily due to shifts in customer replenishment orders and comparatively higher demand in the first half of FY2025. This dynamic underscores the variability in government-related contracts, where order timing can defer recognition into later periods like H2 FY2026.

Net income totaled $1.3M or $0.19 diluted EPS, a 24.2% decline from $1.8M or $0.26 EPS in Q2 FY2025, aligning with the operating leverage compression. Cash flow from operations shifted to a -$1.3M outflow from $4.0M provided last year, driven by working capital needs including inventory buildup to meet anticipated demand. Capital expenditures rose to $849K from $453K, resulting in free cash flow of -$2.2M, as the company maintains production capacity amid opportunities to utilize excess facilities for new products outside traditional lines.

Business drivers highlight Applied Optics Center strength, with backlog growth from new commercial optical assembly orders attributed to replenishment timing and elevated H1 FY2026 demand versus prior year. However, backlog convertibility remains flexible, as many contracts allow accelerated delivery or schedule adjustments without penalty to align with customer needs. Management notes zero interest expense under the Texas Capital Facility this quarter, secured by operating assets, with future draws at SOFR plus margin. These elements signal disciplined capital management amid investments, setting the stage for revenue recovery as deferred awards materialize.